A
AquaNab
Germany · Biotech · Agritech · Foodtech
AquaNab develops nanoantibody-based treatments for fish diseases, starting with sea lice in salmon farming.
Product
The company designs small, targeted antibodies derived from alpacas to act against pathogens affecting farmed fish. Its development programme aims to deliver treatment through feed, reducing the need to handle fish for chemical or mechanical delousing.
AquaNab’s initial work targets Atlantic salmon, with a broader platform intended for parasitic, bacterial and viral diseases in aquaculture. The treatments are under development as the company works toward proof of concept and eventual commercialization.
Funding history
1 round · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Undisclosed | Undisclosed | Nordic Foodtech VC — Participant |